From October 1, 2023 to December 31, 2023, the company has repurchased 11,511,800 shares, representing 0.6% for CNY 53.54 million. With this, the company has completed the repurchase of 27,531,540 shares, representing 1.42% for CNY 127.48 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 CNY | +0.50% | +2.27% | -8.78% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.78% | 1.06B | |
+43.25% | 6.3B | |
-15.08% | 4.44B | |
-6.70% | 3.27B | |
+5.47% | 3.16B | |
+0.76% | 2.58B | |
+47.75% | 1.96B | |
-5.08% | 1.73B | |
+2.05% | 1.68B | |
-7.08% | 1.63B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.